Aclarion (ACONW) Competitors $0.04 0.00 (-0.26%) As of 10:01 AM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlinesSEC FilingsTrendsBuy This Stock ACONW vs. AONC, DHACW, LFMDP, OTRKP, PIIIW, TALKW, TOIIW, NTRA, FMS, and HIMSShould you be buying Aclarion stock or one of its competitors? The main competitors of Aclarion include American Oncology Network (AONC), Digital Health Acquisition (DHACW), LifeMD (LFMDP), Ontrak (OTRKP), P3 Health Partners (PIIIW), Talkspace (TALKW), Oncology Institute (TOIIW), Natera (NTRA), Fresenius Medical Care (FMS), and Hims & Hers Health (HIMS). These companies are all part of the "healthcare" industry. Aclarion vs. American Oncology Network Digital Health Acquisition LifeMD Ontrak P3 Health Partners Talkspace Oncology Institute Natera Fresenius Medical Care Hims & Hers Health Aclarion (NASDAQ:ACONW) and American Oncology Network (NASDAQ:AONC) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their analyst recommendations, dividends, community ranking, valuation, risk, earnings, profitability, media sentiment and institutional ownership. Which has better earnings & valuation, ACONW or AONC? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAclarion$49.29KN/AN/AN/AN/AAmerican Oncology Network$1.34BN/AN/AN/AN/A Does the media favor ACONW or AONC? In the previous week, American Oncology Network had 1 more articles in the media than Aclarion. MarketBeat recorded 1 mentions for American Oncology Network and 0 mentions for Aclarion. Aclarion's average media sentiment score of 0.00 equaled American Oncology Network'saverage media sentiment score. Company Overall Sentiment Aclarion Neutral American Oncology Network Neutral Does the MarketBeat Community prefer ACONW or AONC? Aclarion and American Oncology Network both received 0 outperform votes by MarketBeat users. CompanyUnderperformOutperformAclarionN/AN/AAmerican Oncology NetworkN/AN/A Is ACONW or AONC more profitable? Company Net Margins Return on Equity Return on Assets AclarionN/A N/A N/A American Oncology Network N/A N/A N/A SummaryAmerican Oncology Network beats Aclarion on 2 of the 2 factors compared between the two stocks. Remove Ads Get Aclarion News Delivered to You Automatically Sign up to receive the latest news and ratings for ACONW and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ACONW vs. The Competition Export to ExcelMetricAclarionHealth Information Services IndustryMedical SectorNASDAQ ExchangeMarket CapN/A$186.24M$4.98B$6.96BDividend YieldN/A6.68%5.34%4.26%P/E RatioN/A208.4521.0617.01Price / SalesN/A412.92337.1183.80Price / CashN/A47.1438.1534.66Price / BookN/A4.865.883.59Net IncomeN/A-$15.55M$3.19B$247.38M7 Day PerformanceN/A-4.31%-8.75%-10.18%1 Month PerformanceN/A-7.52%-6.60%-13.07%1 Year PerformanceN/A-3.10%-0.41%-11.43% Aclarion Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ACONWAclarionN/A$0.04-0.3%N/AN/A$0.00$49,289.000.007AONCAmerican Oncology NetworkN/A$5.00+0.6%N/A-15.4%$0.00$1.34B0.001,520Positive NewsDHACWDigital Health AcquisitionN/A$0.04flatN/AN/A$0.00N/A0.00N/ALFMDPLifeMDN/A$26.50+5.0%N/A+1.3%$0.00$212.45M0.00230High Trading VolumeOTRKPOntrakN/A$0.23-0.8%N/A-60.9%$0.00$10.84M0.00250Upcoming EarningsHigh Trading VolumePIIIWP3 Health PartnersN/A$0.01+1.7%N/AN/A$0.00$1.48B0.00500Gap DownTALKWTalkspaceN/A$0.09+3.0%N/A-52.0%$0.00$187.59M0.00500Gap UpTOIIWOncology InstituteN/A$0.02-12.5%N/AN/A$0.00$393.41M0.00660Positive NewsNTRANatera3.683 of 5 stars$140.65-0.5%$178.12+26.6%+38.6%$19.01B$1.70B-79.913,020Positive NewsFMSFresenius Medical Care3.8046 of 5 stars$24.75-0.6%$25.30+2.2%+19.2%$14.52B$19.34B20.45123,200Positive NewsHIMSHims & Hers Health3.6766 of 5 stars$31.04+5.0%$37.31+20.2%+74.9%$6.90B$1.48B70.54650High Trading Volume Remove Ads Related Companies and Tools Related Companies AONC Alternatives DHACW Alternatives LFMDP Alternatives OTRKP Alternatives PIIIW Alternatives TALKW Alternatives TOIIW Alternatives NTRA Alternatives FMS Alternatives HIMS Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ACONW) was last updated on 4/9/2025 by MarketBeat.com Staff From Our PartnersTrump’s Secret WeaponHave you looked at the stock market recently? Millions of investors are scrambling trying to figure out what's...American Alternative | Sponsored[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredElon’s 2025 Silver Crisis (What It Means for You)Silver isn't just a safe haven for your wealth—it's a critical resource in the global tech and energy race. Wi...GoldenCrest Metals | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | SponsoredAll Signs Point To Collapse - 401(k)s/IRAs /Are DoomedRetiring? Not so Fast..Hold Onto Your Bootstraps For A Long Road AheadAmerican Hartford Gold | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredElon’s Silver Play? Trump Clears the PathNothing is confirmed—yet. But Musk has disrupted every industry he's touched, and Trump's policies make the ti...Priority Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aclarion, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aclarion With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
